| Measures |
Criterion for recovery |
| 1. Unified Parkinson’s disease rating scale (MDS-UPDRS) |
A clinically meaningful reduction in signs and symptoms |
| 2. Changes in medication |
A meaningful reduction in L-DOPA and other medications aiming to up regulate the dopaminergic system |
| 3. Response to medication |
Increases in ‘on time’; decreases in ‘off-time’ and drug induced dyskinesias |
| 4. Activities of Daily Living (ADL) |
Meaningful improvements in the execution of personally and socially relevant tasks |
| 5. Self assessed global change in disease impact |
Improvement in condition in comparison to baseline |
| 6. Quality of Life (QAL) |
Self perceived, meaningful increases in health, physical and emotional wellbeing |
